Principal InvestigatorNIHBethesda, Maryland, United States
P78. Casein kinase II inhibition with proteosome inhibition demonstrates therapeutic potential in gastroenteropancreatic neuroendocrine tumor liver metastases via abrogation of NFκB signaling
Thursday, March 5, 20264:37 PM - 4:44 PM MST
RFP7. IL-13 levels are elevated in floxuridine-treated patient plasma and ex vivo cystic duct perfusates
Friday, March 6, 20264:59 PM - 5:06 PM MST
P115. Clusterin may act as a potential biomarker for tumorigenesis in CDH1-related hereditary diffuse gastric cancers
Saturday, March 7, 20268:53 AM - 9:00 AM MST
P100. Continuous exposure to proteasome inhibition leads to increased cytotoxicity in colorectal liver metastases
Saturday, March 7, 20269:49 AM - 9:56 AM MST
